On September 22, 2021, Santhera Pharmaceuticals Holding AG announced an equity financing of CHF 20 million via a private placement of shares, a placement of private convertible bonds of CHF 15 million and upsizing of an existing financing arrangement of up to CHF 10 million. In addition, Santhera agreed to issue warrants to participating investors.